Boops Pets is Using Ixoreal Biomed's Ingredient
References: prnewswire
Ixoreal Biomed, the developer of the specialized KSM-66 Ashwagandha extract, has announced that its clinically studied ingredient is being incorporated into a new wellness product from the pet brand Boops Pets. The innovation is a Calming and Stress Relief supplement formulated specifically for dogs and designed to address the growing prevalence of fear and anxiety in canines.
Boops Pets leverages KSM-66 Ashwagandha, which is distinguished as the only ashwagandha extract on the market backed by clinical research and a significant number of certifications pertaining to safety and manufacturing quality. This adaptogenic herb is recognized for its ability to help regulate cortisol — the primary stress hormone — thereby supporting a healthy response to environmental triggers. The supplement aims to promote a state of calmness in dogs, helping them cope more effectively with common stressors such as loud noises, travel, or periods of separation from their owners.
Image Credit: Ixoreal Biomed
Boops Pets leverages KSM-66 Ashwagandha, which is distinguished as the only ashwagandha extract on the market backed by clinical research and a significant number of certifications pertaining to safety and manufacturing quality. This adaptogenic herb is recognized for its ability to help regulate cortisol — the primary stress hormone — thereby supporting a healthy response to environmental triggers. The supplement aims to promote a state of calmness in dogs, helping them cope more effectively with common stressors such as loud noises, travel, or periods of separation from their owners.
Image Credit: Ixoreal Biomed
Trend Themes
-
Adaptogenic Pet Supplements — Integration of adaptogens like clinically studied Ashwagandha into dog supplements signals the emergence of ingredient-driven calming products that bridge human and pet wellness formulations.
-
Clinically Validated Ingredient Adoption — Growing use of ingredients backed by human clinical data points to elevated consumer expectations for efficacy and third-party certifications in the pet product aisle.
-
Humanization of Pet Health — Rising demand for human-grade safety and research standards in pet care indicates a shift toward premium, science-forward offerings that mirror owner healthcare trends.
Industry Implications
-
Pet Nutraceuticals — Formulation of targeted supplements for stress and anxiety in pets presents opportunities for differentiated dosage forms, tailored delivery, and evidence-focused positioning.
-
Veterinary Care Services — Veterinary clinics and behaviorists incorporating clinically supported nutraceuticals alongside treatment plans could reshape preventive and integrative animal care models.
-
Functional Ingredient Suppliers — Suppliers of clinically validated botanical extracts are positioned to expand into animal-specific lines and certification pathways that meet stringent manufacturing and safety requirements.
6.3
Score
Popularity
Activity
Freshness
